Drug resistance in influenza A virus: the epidemiology and management
M Hussain, HD Galvin, TY Haw… - Infection and drug …, 2017 - Taylor & Francis
Influenza A virus (IAV) is the sole cause of the unpredictable influenza pandemics and
deadly zoonotic outbreaks and constitutes at least half of the cause of regular annual …
deadly zoonotic outbreaks and constitutes at least half of the cause of regular annual …
Clinical implications of antiviral resistance in influenza
Influenza is a major cause of severe respiratory infections leading to excessive
hospitalizations and deaths globally; annual epidemics, pandemics, and sporadic/endemic …
hospitalizations and deaths globally; annual epidemics, pandemics, and sporadic/endemic …
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
AC Hurt, T Chotpitayasunondh, NJ Cox… - The Lancet infectious …, 2012 - thelancet.com
Summary Influenza A H1N1 2009 virus caused the first pandemic in an era when
neuraminidase inhibitor antiviral drugs were available in many countries. The experiences …
neuraminidase inhibitor antiviral drugs were available in many countries. The experiences …
Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition
CJ Vavricka, Q Li, Y Wu, J Qi, M Wang, Y Liu… - PLoS …, 2011 - journals.plos.org
The 2009 H1N1 influenza pandemic (pH1N1) led to record sales of neuraminidase (NA)
inhibitors, which has contributed significantly to the recent increase in oseltamivir-resistant …
inhibitors, which has contributed significantly to the recent increase in oseltamivir-resistant …
Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic
S Kumar, KJ Henrickson - Clinical microbiology reviews, 2012 - Am Soc Microbiol
The menu of diagnostic tools that can be utilized to establish a diagnosis of influenza is
extensive and includes classic virology techniques as well as new and emerging methods …
extensive and includes classic virology techniques as well as new and emerging methods …
Influenza: epidemiology, clinical features, therapy, and prevention
NM Clark, JP Lynch - Seminars in respiratory and critical care …, 2011 - thieme-connect.com
Influenza A and B are important causes of respiratory illness in all age groups. Influenza
causes seasonal outbreaks globally and, less commonly, pandemics. In the United States …
causes seasonal outbreaks globally and, less commonly, pandemics. In the United States …
Preclinical and clinical developments for combination treatment of influenza
P Koszalka, K Subbarao, M Baz - PLoS Pathogens, 2022 - journals.plos.org
Antiviral drugs are an important measure of control for influenza in the population,
particularly for those that are severely ill or hospitalised. The neuraminidase inhibitor (NAI) …
particularly for those that are severely ill or hospitalised. The neuraminidase inhibitor (NAI) …
Antivirals targeting the surface glycoproteins of influenza virus: Mechanisms of action and resistance
Y Bai, JC Jones, SS Wong, M Zanin - Viruses, 2021 - mdpi.com
Hemagglutinin and neuraminidase, which constitute the glycoprotein spikes expressed on
the surface of influenza A and B viruses, are the most exposed parts of the virus and play …
the surface of influenza A and B viruses, are the most exposed parts of the virus and play …
Does respiratory virus coinfection increases the clinical severity of acute respiratory infection among children infected with respiratory syncytial virus?
Y Harada, F Kinoshita, LM Yoshida… - The Pediatric …, 2013 - journals.lww.com
Background: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory
infection in children less than 5 years of age. The impact of non-RSV respiratory virus …
infection in children less than 5 years of age. The impact of non-RSV respiratory virus …
Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses
The influenza virus is highly contagious in human populations around the world and results
in approximately 250,000–500,000 deaths annually. Vaccines and antiviral drugs are …
in approximately 250,000–500,000 deaths annually. Vaccines and antiviral drugs are …